Photodynamic therapy with hexenyl ester of 5-aminolevulinic acid induces necrotic cell death in salivary gland adenocarcinoma cells

Oncology Reports

Volumn 24, Issue 1, 2010, Pages 177-181

  Park, Jong Hwan ^a   Moon, Yeon Hee ^b   Kim, Dong Jae ^b   Kim, Soo A ^c   Lee, Jee Bum ^d   Ahn, Sang Gun ^b   Yoon, Jung Hoon ^b  

^a Konyang University   (South Korea)

^b Chosun University   (South Korea)

^c Dongguk University   (South Korea)

^d Chonnam National University Medical School   (South Korea)

Author keywords

Hexenyl ester of 5 aminolevulinic acid; Photodynamic therapy; Salivary gland adenocarcinoma

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 5 AMINOLAEVULINIC ACID HEXENYL ESTER; AMINOLEVULINIC ACID; ANTINEOPLASTIC AGENT; COPROPORPHYRINOGEN OXIDASE; LACTATE DEHYDROGENASE; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; 5-AMINOLEVULINIC ACID HEXYL ESTER;

ADENOCARCINOMA; ARTICLE; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CANCER INHIBITION; CARCINOMA CELL; CELL ASSAY; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; IN VIVO STUDY; LIGHT EMITTING DIODE; OXIDATIVE STRESS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVARY GLAND ADENOCARCINOMA; SALIVARY GLAND CARCINOMA; ANALOGS AND DERIVATIVES; ANIMAL; CELL SURVIVAL; CHEMICALLY INDUCED; CHICK EMBRYO; DRUG EFFECTS; EVALUATION STUDY; GENETICS; METABOLISM; NECROSIS; PATHOLOGY; PHOTOCHEMOTHERAPY; PROCEDURES; SALIVARY GLAND NEOPLASMS; TUMOR CELL LINE; TUMOR INVASION;

ADENOCARCINOMA; AMINOLEVULINIC ACID; ANIMALS; ANTINEOPLASTIC AGENTS; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; CHICK EMBRYO; COPROPORPHYRINOGEN OXIDASE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NECROSIS; NEOPLASM INVASIVENESS; PHOTOCHEMOTHERAPY; REACTIVE OXYGEN SPECIES; SALIVARY GLAND NEOPLASMS;

EID: 77953002201     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00000843     Document Type: Article

References (27)

1. Etges A, Nunes FD, Ribeiro KC and Araujo VC: Immunohistochemical expression of retinoblastoma pathway proteins in normal salivary glands and in salivary gland tumours. Oral Oncol 40: 326-331, 2004. (Pubitemid 38121571)
2. Milano A, Longo F, Basile M, Iaffaioli RV and Caponigro F: Recent advances in the treatment of salivary gland cancers: emphasis on molecular targeted therapy. Oral Oncol 43: 729-734, 2007. (Pubitemid 47259451)
3. Prenen H, Kimpe M and Nuyts S: Salivary gland carcinomas: molecular abnormalities as potential therapeutic targets. Curr Opin Oncol 20: 270-274, 2008. (Pubitemid 351507546)
4. Barnes L, Everson JW and Reichart P: World Health Organization classification of tumours. IARC Press, Lyon, 2005.
5. Spiro RH: Management of malignant tumors of the salivary glands. Oncology 12: 671-683, 1998.
6. Dodd RL and Slevin NJ: Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies. Oral Oncol 42: 759-769, 2006.
7. Kelty CJ, Brown NJ, Reed MW and Ackroyd R: The use of 5-aminolaevulinic acid as a photosensitiser in photodynamic therapy and photodiagnosis. Photochem Photobiol Sci 1: 158-168, 2002. (Pubitemid 37069724)
8. Sharma S, Jajoo A and Dube A: 5-Aminolevulinic acid-induced protoporphyrin-IX accumulation and associated phototoxicity in macrophages and oral cancer cell lines. J Photochem Photobiol B 88: 156-162, 2007. (Pubitemid 47382620)
9. van den Akker JT, Iani V, Star WM, Sterenborg HJ and Moan J: Topical application of 5-aminolevulinic acid hexyl ester and 5-aminolevulinic acid to normal nude mouse skin: differences in protoporphyrin IX fluorescence kinetics and the role of the stratum corneum. Photochem Photobiol 72: 681-689, 2000.
10. Castano AP, Demidova TN and Hamblin MR: Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization. Photodiagnosis Photodyn Ther 1: 279-293, 2004.
11. Tsai T, Hong RL, Tsai JC, Lou PJ, Ling IF and Chen CT: Effect of 5-aminolevulinic acid-mediated photodynamic therapy on MCF-7 and MCF-7/ADR cells. Lasers Surg Med 34: 62-72, 2004. (Pubitemid 38101761)
12. Wu RW, Chu ES, Yow CM and Chen JY: Photodynamic effects on nasopharyngeal carcinoma (NPC) cells with 5-aminolevulinic acid or its hexyl ester. Cancer Lett 242: 112-119, 2006. (Pubitemid 44485299)
13. Gerscher S, Connelly JP, Griffiths J, et al: Comparison of the pharmacokinetics and phototoxicity of protoporphyrin IX metabolized from 5-aminolevulinic acid and two derivatives in human skin in vivo. Photochem Photobiol 72: 569-574, 2000.
14. Marti A, Jichlinski P, Lange N, et al: Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer. J Urol 170: 428-432, 2003. (Pubitemid 36870217)
15. Brunner H, Hausmann F and Knuechel R: New 5-aminolevulinic acid esters - efficient protoporphyrin precursors for photo-detection and photodynamic therapy. Photochem Photobiol 78: 481-486, 2003.
16. Perotti C, Fukuda H, DiVenosa G, MacRobert AJ, Batlle A and Casas A: Porphyrin synthesis from ALA derivatives for photodynamic therapy. In vitro and in vivo studies. Br J Cancer 90: 1660-1665, 2004.
17. Wu SM, Ren QG, Zhou MO, Peng Q and Chen JY: Protoporphyrin IX production and its photodynamic effects on glioma cells, neuroblastoma cells and normal cerebellar granule cells in vitro with 5-aminolevulinic acid and its hexylester. Cancer Lett 200: 123-131, 2003. (Pubitemid 38366092)
18. Lee JB, Choi JY, Chun JS, et al: Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin. Br J Dermatol 159: 61-67, 2008.
19. Moon YH, Park JH, Kim SA, Lee JB, Ahn SG and Yoon JH: Anticancer effect of photodynamic therapy with hexenyl ester of 5-aminolevulinic acid in oral squamous cell carcinoma. Head and Neck, Epub ahead of print, 2009.
20. Shrestha P, Sumitomo S, Lee CH, et al: Tenascin: growth and adhesion modulation - extracellular matrix degrading function: an in vitro study. Eur J Cancer B Oral Oncol 32B: 106-113, 1996. (Pubitemid 26153213)
21. Sinha AK, Anand S, Ortel BJ, et al: Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells. Br J Cancer 95: 485-495, 2006. (Pubitemid 44232558)
22. Hosokawa Y, Shirato H, Kagei K, et al: Role of radiotherapy for mucoepidermoid carcinoma of salivary gland. Oral Oncol 35: 105-111, 1999. (Pubitemid 28546852)
23. Agulnik M and Siu LL: An update on the systemic therapy of malignant salivary gland cancers: role of chemotherapy and molecular targeted agents. Curr Med Chem Anticancer Agents 4: 543-551, 2004. (Pubitemid 39406266)
24. Frimberger AE, Moore AS, Cincotta L, Cotter SM and Foley JW: Photodynamic therapy of naturally occurring tumors in animals using a novel benzophenothiazine photosensitizer. Clin Cancer Res 4: 2207-2218, 1998. (Pubitemid 28415669)
25. Hsieh YJ, Wu CC, Chang CJ and Yu JS: Subcellular localization of Photofrin determines the death phenotype of human epidermoid carcinoma A431 cells triggered by photodynamic therapy: when plasma membranes are the main targets. J Cell Physiol 194: 363-375, 2003.
26. Lu Z, Tao Y, Zhou Z, et al: Mitochondrial reactive oxygen species and nitric oxide-mediated cancer cell apoptosis in 2-butylamino-2- demethoxyhypocrellin B photodynamic treatment. Free Radic Biol Med 41: 1590-1605, 2006. (Pubitemid 44528256)
27. Nowis D, Makowski M, Stoklosa T, Legat M, Issat T and Golab J: Direct tumor damage mechanisms of photodynamic therapy. Acta Biochim Pol 52: 339-352, 2005. (Pubitemid 41133769)